The life sciences sector is at a crossroads as the FDA updates quality management standards. AI is now expected, and the FDA’s January 2025 draft guidance outlines its evaluation and implementation. Successful adoption depends on three key questions.
Safe and Sane: Understanding the FDA’s Risk-Based Approach to AI
Related Posts
Maximizing Medical Device Quality: AGuide to Implementing OperationalExcellence
Ensuring high quality in medical device manufacturing requires operational excellence, which optimizes efficiency and enhances product quality and…
Handheld CMM Helps MRO Shop Enhance Inspection
JETAIR SUPPORT specializes in the inspection and maintenance of aviation components, including life-limited parts that are crucial to…
Importance of Compliance Testing for Digital Transformation
The Evolving Dynamics of Digital Business Understanding Compliance in the Digital Age Why Compliance Testing is Crucial for…
